0 Комментарии
0 Поделились
27 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
The 2026 CD47 Targeting Therapeutics Market: Pioneering the "Don’t Eat Me" Signal Suppression EraIn the sophisticated landscape of 2026, oncology has moved beyond simple cell destruction to a strategic mastery of the immune system. The CD47 Targeting Therapeutics Market represents the cutting edge of this shift, focusing on a transmembrane protein that acts as a "don’t eat me" signal for cancer cells. By blocking this checkpoint, these next-generation therapies enable...0 Комментарии 0 Поделились 233 Просмотры 0 предпросмотр
-
The 2026 CD47 Targeting Therapeutics Market: Pioneering the "Don’t Eat Me" Signal Suppression EraIn the sophisticated landscape of 2026, oncology has moved beyond simple cell destruction to a strategic mastery of the immune system. The CD47 Targeting Therapeutics Market represents the cutting edge of this shift, focusing on a transmembrane protein that acts as a "don’t eat me" signal for cancer cells. By blocking this checkpoint, these next-generation therapies enable...0 Комментарии 0 Поделились 219 Просмотры 0 предпросмотр